Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 19/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.49 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL6184381 | 0.90 | DPP4 (0.49) | DPP4OPRM1OPRD1DPP8 | |
| Trifluoroacetic Acid SCHEMBL6185476 | 0.89 | DPP4 (0.53) | DPP4OPRM1OPRD1DPP8 | |
| Trifluoroacetic Acid SCHEMBL6185958 | 0.85 | DPP4 (0.50) | DPP4OPRM1OPRD1DPP8 | |
| Trifluoroacetic Acid SCHEMBL6182699 | 0.84 | DPP4 (0.52) | DPP4DPP8 | |
| Trifluoroacetic Acid SCHEMBL6182706 | 0.83 | DPP4 (0.56) | DPP4OPRM1OPRD1DPP8 | |
| Trifluoroacetic Acid SCHEMBL6184030 | 0.81 | DPP4 (0.52) | DPP4OPRM1OPRD1DPP8 | |
| Trifluoroacetic Acid SCHEMBL6184620 | 0.78 | DPP4 (0.60) | DPP4DPP8 | |
| Trifluoroacetic Acid SCHEMBL6185214 | 0.75 | DPP4 (0.75) | DPP4OPRM1OPRD1 | |
| Trifluoroacetic Acid SCHEMBL6185212 | 0.75 | DPP4 (0.75) | DPP4OPRM1OPRD1 | |
| Trifluoroacetic Acid SCHEMBL6187968 | 0.75 | KDM4E (0.53) | DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050256166-A1 | Nitrogen-containing compounds | ONO PHARMACEUTICAL CO., LTD. (JP) | 2005-11-17 | — | — | US | disclosed |
| EP-1535906-A1 | NITROGEN-CONTAINING COMPOUNDS | ONO PHARMACEUTICAL CO., LTD. (JP) | 2005-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256166-A1 | Nitrogen-containing compounds | DPP4, DPP3, DPP8 | DPP4 1/4885OPRM1 2097/4885OPRD1 2888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.